Serial Number
79345925
Owner
SCT CELL MANUFACTURING S.R.O.Attorney
Shane RumbaughFiling Date
Apr 14, 2022
SCT BIO Trademark
Serial Number: 79345925 • Registration: 7238443
Trademark Classes
Owner Contact Info
JANKOVCOVA 1518/2
CZ-170 00 PRAGUE 7 , CZ
Entity Type: 99
Legal Representation
Correspondence Address
Shane Rumbaugh Rumbaugh Law PLLC
2400 Ansys Drive, Suite 102
Canonsburg, PA 15317
United States
Trademark Details
Filing Date
April 14, 2022
Registration Date
December 12, 2023
Published for Opposition
September 26, 2023
Goods & Services
Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, tcr-t therapy materials, namely, T cell receptor T cell-based pharmaceuticals, or car-nk therapy materials, namely, chimeric antigen receptor natural killer cell-based pharmaceuticals to the order and specification of others
Packaging services in the nature of applications of labels to cell therapy materials; storage and distribution of cell therapy materials
Pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; scientific research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; consultation in the field of pharmaceutical research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; product research and development, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; biological materials testing services and biological laboratory services, namely, for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, and car-nk therapies
